Vascular Endothelial Growth Factor (VEGF) has been typically considered to be an endothelial-specific growth factor. However, it was recently demonstrated that VEGF can interact with non endothelial cells. In this study, we tested whether vascular smooth muscles cells (VSMCs) can express VEGF recept
Rho expression and activation in vascular smooth muscle cells
โ Scribed by Worth, Nathalie F. ;Campbell, Gordon R. ;Campbell, Julie H. ;Rolfe, Barbara E.
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 661 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0886-1544
- DOI
- 10.1002/cm.20036
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract It has been shown that rat aortic smooth muscle cells (AoSMCs) lost PKGโI expression when propagated repetitively or grown at low densities. Conversely, AoSMCs isolated from PKGโI deficient mice are indistinguishable from those isolated from normal mice in morphology and growth characte
The binding, internalization, and metabolism of 13H]-heparin by human umbilical vein endothelial cells (HUVEC) and human umbilical arterial smooth muscle cells (HUASMC) have been characterized using 5ize-exclusion HPLC. Incubation of HUVEC with ['HI-heparin demonstrated selective binding of high-mol
## Abstract To dissect the effect of hyperinsulinemia versus hyperglycemia on TNFโrelated apoptosis inducing ligand (TRAIL) expression in the macrovascular district, we measured TRAIL mRNA and protein in four groups of animals: streptozotocin (SZT)โinduced diabetic rats, vehicleโtreated control ani
CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apoptosis of activated infiltrating T lymphocytes. Therefore, progressive tumors might express high levels of FasL and develop as immune privileged sites. In this study, we investigated the expression of